Emergency Medicine Pharmacist Prescriptive Authority for Resolution of Outpatient Prescription Issues

NCT06222424 — Not applicable, Completed, 350 participants, Methodist Health System

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Emergency Medicine Pharmacist Prescriptive Authority for Resolution of Outpatient Prescription Issues: A Descriptive Study

RegistryNCT06222424
StatusCompleted
PhaseNot applicable
Study typeInterventional; na, single group, masking: none, supportive care
Enrollment350 (Actual)
SponsorMethodist Health System (Other)
ConditionsOutpatient Prescription Issues
Interventionsoutpatient prescription issues (Other)
Datesstart 2023-12-15, primary completion 2026-03-01, completion 2026-03-15, first posted 2024-01-24, last updated 2026-03-23
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Outpatient Prescription Issues All trials of outpatient prescription issues

-Summary

The study aims to document the utility of Methodist Charlton Medical Center (MCMC's)Emergency Medicine Pharmacist (EMP) Collaborative Practice Agreement (CPA )utilization for the resolution of outpatient prescription issues. Evaluation of utility will involve describing all EMP-written prescriptions pursuant to resolution of prescription issues realized after discharge.

Expand all sections  ·  Collapse all

+Detailed description

Use of an EMP CPA, which allows for broad prescriptive authority, will assist Emergency Department (ED )workflow by preventing a significant volume of new prescriptions needing to be sent by physician and mid-level providers. Will improve rates of ED re-visits. In addition, this Collaborative Practice Agreement (CPA) will not be associated with a large volume of new prescription errors.

+Arms and interventions

ArmTypeInterventionsDescription
Patients at MCMC who had a prescription sent by an EMP between November 1, 2021 and June 30, 2023OtherOther: outpatient prescription issuesEvaluation of utility will involve describing all EMP-written prescriptions pursuant to resolution of prescription issues realized after discharge.
  • outpatient prescription issues (Other): Evaluation of utility will involve describing all Emergency Medicine Pharmacist (EMP)-written prescriptions pursuant to resolution of prescription issues realized after discharge

+Outcome measures

Primary outcomes

  • Number of prescriptions and medication types sent to outpatient pharmacies [2 years]: Number of prescriptions and medication types sent to outpatient pharmacies by EMPs pursuant to outpatient prescription issue resolution.

Secondary outcomes

  • Number of patients returning with complaint or diagnosis related to EMP generated prescriptions [2 years]: Proportion of patients returning with a complaint or diagnosis related to index EMP-generated prescriptions at three and six-month time points

+Eligibility

Sex: All

Inclusion Criteria:

* Patients at MCMC who had a prescription sent by an EMP between November 1, 2021 and June 30, 2023 and a progress note and documenting the reason for the call and action taken by the EMP.

Exclusion Criteria:

* CPA actions were misclassified as discharge prescription issue resolutions.
* Patients with prescriptions pursuant to late culture review, formulation changes not requiring a new prescription, prescription transfers to another pharmacy, or simple retransmission of prescriptions.
* Patients documented to have left the ED against medical advice.

+Locations (1)

FacilityCityCountryStatus
Clinical Research Institute at Methodist Health SystemDallas, TexasUnited States

+Investigators